Bruce Close is VP, Quality and Compliance at Acrivon Therapeutics, Inc. Previously, he was a Principal Quality Consultant at Halloran Consulting. From 2007 to 2020, Bruce served as Executive Director, Compliance Operations at Celgene, where he focused on GxP regulatory and healthcare compliance. Prior to Celgene, he was in Compliance and Quality at Schering Ag / Bayer directing quality improvement initiatives and GMP auditing and training. Bruce held a similar role at Regeneron with responsibility for GLP Quality Assurance. Earlier in his career, he was a scientist at Baxter. Bruce received a B.S. and a B.A. from Rutgers University and a M.S. in Jurisprudence from Seton Hall University.